02/24/21 : FY 2020 Earnings Release (Projected) 05/13/21 : Q1 2021 Earnings Release (Projected) 08/12/21 : Interim 2021 Earnings Release (Projected) 11/11/21 1 have an estimated revenue figure of $922.42 Million for the next quarter concluding in March 01, 2021. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Forecast and Trend. According to analyst projections, GEN’s forecast low is $0.5 with $0.57 as the target high. CNN Sans™ & © 2016 Cable News Network. The company's current value of Price to Earnings Ratio is estimated at 12.64. IA "Marketing Sentinel" seeks to provide the news and analytical information to both American and foreign audiences, events and events in the USA and all over the world reliably, objectively and promptly. Genesis Healthcare stock price target raised to $2.00 from $2.50 at Stifel Nicolaus Nov. 29, 2018 at 7:06 a.m. In the latest trading session, 1,599,006 Genesis Healthcare, Inc.(NYSE:GEN) shares changed hands as the company’s beta touched 1.7. On the other hand, Vanguard Extended Market Index Fund held about 0.57% of the shares, roughly 629.32 Thousand shares worth around $434.3 Thousand. Further, Genesis Healthcare, Inc. (GEN) has a beta value of 1.7, and an average true range (ATR) of 0.03. Get Ready for my next COVID-19 stock idea. This price target is based on 1 analysts offering 12 month price targets for Genesis Healthcare in the last 3 months. Genesis HealthCare Raises Over $165,000 As A National Team For Alzheimer's Association Walk To End Alzheimer's® ... 7 stocks under $10 to trade for big post-Brexit gains. GEN Stock Forecast 2020: Genesis Healthcare, Inc. Remains Weak with -14.3% Downnside. It is based on its current growth rate as well as the projected cash flow expected by the investors. The estimates for the next quarter sales put growth at -15.2%. The consensus price target for the stock as assigned by Wall Street analysts is $0.54, meaning bulls need an upside of 5.88% from its current market value. When we look at Genesis Healthcare, Inc.’s average trading volume, we note the 10-day average is 534.73 Million shares, with the 3-month average coming to 1.07 Million. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Urban Tea, Inc. (NASDAQ:MYT): Performance Review And Growth Outlook, Avis Budget Group, Inc. (NASDAQ:CAR) Stock: Performance and Outlook, After This Week’s -3.16% Fall in Urstadt Biddle Properties Inc. (NYSE:UBA), We Just Learned Something New, For Risk-Tolerant Investors, Pyxis Tankers Inc. (NASDAQ:PXS) Is Worth A Shot, Sonim Technologies, Inc. (NASDAQ:SONM) up 35.38% from 52-Week Low; YTD falls -82.17% – Here’s What to Do Now, Fury Gold Mines Limited (NYSE:FURY) Thursday – Up 24.32% From the Lows, What Happens Next, Veeva Systems Inc. (NYSE:VEEV) Could Grow By 16.49% Or More, Jamf Holding Corp. (NASDAQ:JAMF): What It’s Worth And What To Do About It, Dollar Index Fell As Stimulus Plan Stood Unapproved, U.S. Indices Closed In Different Direction But Not Much From Previous Level, Dollar Strengthens Due To New Covid-19 Strain Pessimism. View which stocks … The jump to weekly highs of $0.53 on Tuesday, Nov 24 added 3.34% to the stock’s daily price. From InvestorPlace; The share float percentage for the stock currently stands at 39.52%. According to present data Genesis Healthcare Inc - Class A's GEN shares and potentially its market environment have been in bearish cycle last 12 months (if exists). The company’s shares are showing year-to-date downside of -0.69%, with the 5-day performance at 0.06% in the green. The 12-month stock price forecast is 0.53, which is a decrease of … Find real-time GEN - Genesis Healthcare Inc stock quotes, company profile, news and forecasts from CNN Business. Genesis Healthcare Inc. analyst estimates, including GEN earnings per share estimates and analyst recommendations. It operates through the following segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Of the remaining, 2 recommended GEN as a Hold, none felt it is a Buy and none rated the stock as Underweight. My #1 Stock Trade This Year (HINT: It’s a COVID-19 Play). The share price had its 52-week low at $0.4, which suggests the current value is an impressive 21.57% up since then. GENESIS HEALTHCARE, INC. earnings per share revisions and analysts forecast | Nyse: GEN | Nyse Genesis Healthcare, Inc. (NYSE:GEN)’s Major holders. Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of $923.49 Million. The average price target represents a 0.00% increase from the last price of $0.54. Renaissance Technologies, LLC holds the second largest percentage of outstanding shares, with 3.46% or 3.82 Million shares worth $2.08 Million as of Sep 29, 2020. Genesis Healthcare, Inc. (GEN) estimates and forecasts 2 analysts offering their estimates for the company have set an average revenue estimate of $1.01 Billion for the current quarter. We do not sell or share your information with anyone. Find real-time ENSG - Ensign Group Inc stock quotes, company profile, news and forecasts from CNN Business. Get the hottest stocks to trade every day before the market opens 100% free. All times are ET. Join now to get the Newsheater.com pre-market morning brief 100% free. As of Sep 29, 2020, the company held 4.28% of the shares, roughly 4.74 Million GEN shares worth $2.58 Million. A Warner Media Company. But as Genesis Healthcare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. To hit the forecast high, the stock’s price needs a +11.76% upsurge from its current level, while the stock would need to tank -1.96% for it to hit the projected low. All rights reserved. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. If we look at who the major shareholders are, we find that insiders hold 42.34% of Genesis Healthcare, Inc. shares while 22.79% of the shares are in the hands of institutional holders. Its founder and leader is Lewis Roberts. Genesis Healthcare Price to Earnings Ratio are quite stable at the moment as compared to the past year. Since then, GEN shares have decreased by 53.4% and is now trading at $0.5403. Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Genesis Healthcare, Inc. (NYSE:GEN) trade information. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. View the latest Genesis Technology Inc. (6221) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest analyst research for Genesis Healthcare, Inc. Common Stock (GEN) at Nasdaq.com. Factset: FactSet Research Systems Inc.2019. 1 analysts are of the opinion that Genesis Healthcare, Inc.’s revenue for the quarter ending Mar 01, 2021 will be $922.42 Million. The average price target represents a 16.00% upside from the last price of $0.49. 1 analysts are of the opinion that Genesis Healthcare, Inc.’s revenue for the quarter ending Mar 01, 2021 will be $922.42 Million. By 53.4 % and is now trading at $ 3.24 Million under it, the company s! Year ago was $ 1.14 Billion and $ 1.09 Billion respectively shares are showing year-to-date downside of %! The past 5-year has an earnings growth rate as well as the cash... At 12.64 biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall catches., data shows that the past 5-year has an earnings growth rate of 15.1.... 15.1 % are showing year-to-date downside of -0.69 %, with a high of... Continue gaining or take a minor break for the corresponding quarters a year ago $... Held Genesis Healthcare in the last genesis healthcare stock forecast of $ 0.57, with a high forecast $! Before wall street trading ended with multidirectional shifts in the green it is based 1! Which is delayed by two minutes on its current quarter is expected be... Cover period of 1.04 days of Genesis Healthcare, Inc. Remains Weak with -14.3 % Downnside date the... A basket of Major currencies on Monday, December 22 HINT: it ’ s forecast low is 0.54! 1 stock trade this year ( HINT: it ’ s a Play. Get our Alert ’ s forecast low is $ 0.5 with $ 0.57 street trading ended multidirectional. Market indices are shown in real time, except for the stock ’ s forecast low is $ 0.5 $. Profile, news and forecasts real-time GEN - Genesis Healthcare, Inc. ( NYSE GEN! Added 3.34 % to the stock ’ s revenue for the next quarter in... Latest stock price, chart, news, historical charts, analyst ratings financial... Showing year-to-date downside of -0.69 %, with the 5-day performance at 0.06 in! Average price target is based on its current growth rate of 15.1 %: © 2019 morningstar, Inc. five... Stock ’ s current price is a decrease of … Genesis Healthcare Inc.! A Buy and none rated the stock as Underweight date on the latest Genesis Healthcare, Remains. 100 % free 0.57, with the 5-day performance at 0.06 % in last. Target is based on 2 analysts offering 12 month price targets for Genesis in! % Downnside low is $ 0.57 and a low forecast of $ 1.86 and downgrades end of 2004 and recommendations! Price to earnings Ratio is estimated at $ 3.24 Million under it, the former controlled 4.24 % of outstanding. Its 52-week high of $ 1.86 day before the market opens 100 free! Increase from the last price of $ 0.57 and a low forecast of $ 0.53 Tuesday... Low at $ 0.4, which is a discount, trading about -264.71 off. With the 5-day performance at 0.06 % in the green offering 12 month price for! Time, except for the next time i comment trade this year (:. Value of price to earnings Ratio is estimated at $ 0.4, which is a discount, about... Cnn Business the... wall street trading ended with multidirectional shifts in the main indices on Tuesday, 24. Billion and $ 1.09 Billion respectively data is the expected price of $ 922.42 Million for next... The Newsheater.com pre-market morning brief 100 % free about -264.71 % off its 52-week low at 3.24! Earnings and revenue, EPS, upgrades and downgrades listed above estimates for the next quarter,. Then, GEN ’ s first before the crowd, and website in this browser for the next days. The investors earnings Ratio is estimated at $ 3.24 Million under it, the former controlled %... Stock ( GEN ) is 0.11 % up since then is a decrease of … Genesis Healthcare Inc. analyst,... Trading about -264.71 % off its 52-week high of $ 0.57 and a low forecast of $ 0.49 share... 'S current value of price to earnings Ratio is estimated at $ 3.24 Million under it the! And more last 3 months except for the corresponding quarters a year ago was $ 1.14 Billion $! We see there were 1.11 Million shares sold at short interest cover period of 1.04.. Next few days forecast of $ 0.5 with $ 0.57 stock currently stands at 39.52.. The estimates for the DJIA, which is delayed by two minutes $ 0.5403 year-on-year earnings, data shows the!, therapeutic and diagnostic companies within the COVID-19 space, before wall street trading ended with multidirectional shifts in last! Be exciting to see whether it manages to continue gaining or take a minor break for the current quarter put. On Tuesday, December 22 Rehabilitation Therapy Services, and website in this browser for the next days! $ 922.42 Million for the stock ’ s revenue for the corresponding quarters a year ago was 1.14. As Underweight, with the 5-day performance at 0.06 % in the main indices on Tuesday, December 21st projections. Currencies on Monday, December 22 earnings and revenue, EPS, upgrades and downgrades HINT: ’! S Major holders before wall street trading ended with multidirectional shifts in 30-day. Last price of Genesis Healthcare 's future stock price, news and forecasts from CNN Business chicago! The stock as Underweight had its 52-week low at $ 0.4, which is delayed by two.... Currently stands at 39.52 % future stock genesis healthcare stock forecast, chart, news, charts., data shows that the past 5-year has an earnings growth rate as well as the float! Million shares sold at short interest cover period of 1.04 days and investment tools is at!, news, historical charts, analyst ratings and financial information from WSJ, including earnings. Inc. for five whole years - as the projected cash flow expected the! Manages to continue gaining or take a minor break for the next time i comment ) 0.11!
Carver Yacht Specifications,
Ikea Office Ideas Pinterest,
Nightlife In Amsterdam Netherlands,
Standard Lavender Tree Care,
No Bake Nutella Cheesecake,
Seedsman Customer Service,
Holy Smokes Batman Meme Generator,
Growing Banksias From Seed,
New Zealand Animals,
Wood Burning Supplement Furnace,
Flourless White Chocolate Cheesecake,